The aim of the present study was to evaluate the efficacy and safety of combination therapy with PDE5I and topical alprostadil in patients with ED non-responders to PDE5I alone. Patients over 18 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results